| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Quince Therapeutics, Inc. | Director | Employee Stock Option (right to buy) | 27K | Jun 5, 2024 | Direct | ||
| BioXcel Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 17K | Jun 10, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BTAI | BioXcel Therapeutics, Inc. | Jun 10, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
| QNCX | Quince Therapeutics, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
| BTAI | BioXcel Therapeutics, Inc. | Jun 26, 2023 | 1 | $0 | 4 | Jun 28, 2023 | Director |
| QNCX | Quince Therapeutics, Inc. | May 24, 2023 | 1 | $0 | 4 | May 26, 2023 | Director |
| QNCX | Cortexyme, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
| QNCX | Cortexyme, Inc. | Jun 9, 2022 | 0 | $0 | 3 | Jun 10, 2022 | Director |
| BTAI | BioXcel Therapeutics, Inc. | May 19, 2022 | 1 | $0 | 4 | May 23, 2022 | Director |
| BTAI | BioXcel Therapeutics, Inc. | Jun 11, 2021 | 1 | $0 | 4 | Jun 15, 2021 | Director |